BriaCell Therapeutics Corp (BCTXW) — Financial Flexibility Index
BriaCell Therapeutics Corp (BCTXW) has a Financial Flexibility Index of -2.41x as of January 2026. Free cash flow of $-8.09 Million (operating CF $-8.09 Million minus capex $0.00) represents -2% of total liabilities ($3.35 Million). Check BriaCell Therapeutics Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BriaCell Therapeutics Corp Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for BriaCell Therapeutics Corp across 20 annual periods. For the full cash flow conversion analysis, see BriaCell Therapeutics Corp cash flow conversion.
Annual Financial Flexibility Index for BriaCell Therapeutics Corp (2006–2025)
Year-by-year free cash flow to debt coverage for BriaCell Therapeutics Corp. Explore BCTXW debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.53x | $-28.17 Million | $-28.17 Million | $4.32 Million | ▼ -136.0% |
| 2024 | -2.77x | $-23.67 Million | $-24.13 Million | $8.56 Million | ▼ -260.4% |
| 2023 | -0.77x | $-23.74 Million | $-23.74 Million | $30.94 Million | ▼ -98.2% |
| 2022 | -0.39x | $-12.48 Million | $-12.48 Million | $32.25 Million | ▲ +96.1% |
| 2021 | -9.90x | $-7.75 Million | $-7.75 Million | $782.24K | ▼ -3123.4% |
| 2020 | -0.31x | $-1.16 Million | $-1.16 Million | $3.77 Million | ▲ +91.6% |
| 2019 | -3.66x | $-3.87 Million | $-3.87 Million | $1.06 Million | ▼ -28.8% |
| 2018 | -2.84x | $-3.81 Million | $-3.81 Million | $1.34 Million | ▼ -63.9% |
| 2017 | -1.73x | $-1.54 Million | $-1.54 Million | $885.90K | ▲ +93.0% |
| 2016 | -24.68x | $-1.20 Million | $-1.20 Million | $48.59K | ▼ -209.7% |
| 2015 | -7.97x | $-933.52K | $-935.26K | $117.17K | ▼ -6563.5% |
| 2014 | -0.12x | $-219.72K | $-363.97K | $1.84 Million | ▼ -112.2% |
| 2013 | 0.98x | $73.24K | $-368.52K | $74.46K | ▼ -86.9% |
| 2012 | 7.49x | $2.13 Million | $-381.49K | $283.94K | ▲ +137.2% |
| 2011 | 3.16x | $1.77 Million | $-690.76K | $559.43K | ▼ -46.5% |
| 2010 | 5.91x | $172.30K | $-309.37K | $29.15K | ▲ +369.8% |
| 2009 | -2.19x | $-140.59K | $-140.59K | $64.19K | ▲ +60.8% |
| 2008 | -5.59x | $-87.41K | $-87.41K | $15.64K | ▲ +39.0% |
| 2007 | -9.16x | $-87.76K | $-87.76K | $9.58K | ▼ -13543.1% |
| 2006 | 0.07x | $1.13K | $1.13K | $16.54K | — |